StockData
Teva Pharmaceutical Industries Ltd logo

Teva Pharmaceutical Industries Ltd

TEVANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30
$41.31−0.19 (-0.46%)

Close on Oct 19, 2026Market cap $48.13BP/E 68.9Yield –

Teva Pharmaceutical Industries GAAP Gross Profit Margin by Quarter

GAAP Gross Profit Margin (%) (%)

Teva Pharmaceutical Industries GAAP Gross Profit Margin: 55.5% in Q3 2026, up 4.1 pts from a year earlier. That is the highest of the 15 quarters on record here.

Latest, Q3 2026
55.5%
Period ended Sep 30, 2026
Change on a year earlier
+4.1 pts
51.4% in Q3 2025
History
15 quarters
Since Q4 2021
Sources
11
Documents cited below

Where the Q3 2026 figure comes from

“|| Gross profit margin | 55.5% | 51.4% | 52.4% | 50.1%”

Source: Form 8-K Earnings Release (0001171843-26-007054) ↗

Reported in SEC Form 10-K / Form 10-Q / Form 8-K Earnings Releases.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedGAAP Gross Profit Margin (%) (%)Year on yearSource
Q3 2026Sep 30, 202655.5%+4.1 ptsForm 8-K Earnings Release (0001171843-26-007054) ↗
Q2 2026Jun 30, 202652.0%+1.7 ptsForm 8-K Earnings Release (0001171843-26-004974) ↗
Q1 2026Mar 31, 202649.5%+1.3 ptsForm 8-K Earnings Release (0001171843-26-002796) ↗
Q3 2025Sep 30, 202551.4%+1.8 ptsForm 8-K Earnings Release (0001171843-25-007000) ↗
Q2 2025Jun 30, 202550.3%+1.7 ptsForm 8-K Earnings Release (0001171843-25-004808) ↗
Q1 2025Mar 31, 202548.2%+1.8 ptsForm 8-K Earnings Release (0001171843-25-002849) ↗
Q3 2024Sep 30, 202449.6%+1.5 ptsForm 8-K Earnings Release (0001171843-24-006034) ↗
Q2 2024Jun 30, 202448.6%+2.3 ptsForm 8-K Earnings Release (0001171843-24-004270) ↗
Q1 2024Mar 31, 202446.4%+3.2 ptsForm 8-K Earnings Release (0001171843-25-002849) ↗
Q3 2023Sep 30, 202348.1%+1.7 ptsForm 8-K Earnings Release (0001157523-23-001677) ↗
Q2 2023Jun 30, 202346.3%–Form 8-K Earnings Release (0001171843-24-004270) ↗
Q1 2023Mar 31, 202343.2%–Form 8-K Earnings Release (0001157523-23-000797) ↗
Q4 2022Dec 31, 202245.6%-4.4 ptsForm 8-K Earnings Release (0001157523-23-000205) ↗
Q3 2022Sep 30, 202246.4%–Form 8-K Earnings Release (0001157523-23-001677) ↗
Q4 2021Dec 31, 202150.0%–Form 8-K Earnings Release (0001157523-23-000205) ↗

Cite this data

StockData. (2026). Teva Pharmaceutical Industries GAAP Gross Profit Margin (%), quarterly Q4 2021–Q3 2026 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/ng-gaap-gp-margin

See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.

See a number that looks wrong?